Abstract |
The effect of KW-3635 ( sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl) ethylidene]-6,11-dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate, CAS 127166-41-0), a novel thromboxane A2 (TxA2) receptor antagonist, on collagen-induced coronary ischemia was studied in guinea-pigs. Under pentobarbital anaesthesia, intravenous injection (i.v.) of collagen (1 mg/kg) induced abnormal ECG changes such as ST-T changes, elevation of T-wave arrhythmia and cardiac arrest in severe cases. The changes of ECG (leads I, II and III) were recorded for 10 min following collagen injection. KW-3635 (25-50 mg/kg p.o.) remarkably improved the collagen-induced ischemic ECG changes. The effect of KW-3635 was more potent than those of daltroban, isbogrel and ticlopidine. Neither nifedipine nor propranolol had any effect. The plasma thromboxane B2 level in the KW-3635-treated animals was lower in comparison with those in both the control and daltroban-treated animals. These results suggest that TxA2 may play a role in this model of coronary ischemia and that KW-3635 is effective in the treatment of ischemic heart disease.
|
Authors | M Kawakage, S Shirakura, A Karasawa, M Takeda, I Miki, A Ishii, K Kubo |
Journal | Arzneimittel-Forschung
(Arzneimittelforschung)
Vol. 41
Issue 12
Pg. 1246-50
(Dec 1991)
ISSN: 0004-4172 [Print] Germany |
PMID | 1815524
(Publication Type: Journal Article)
|
Chemical References |
- Benzimidazoles
- Benzoxepins
- Cyclooxygenase Inhibitors
- Phenylacetates
- Sulfonamides
- Thromboxanes
- Thromboxane B2
- Thromboxane A2
- Collagen
- Propranolol
- Nifedipine
- Ticlopidine
- daltroban
- KW 3635
|
Topics |
- Animals
- Arrhythmias, Cardiac
(physiopathology)
- Benzimidazoles
(therapeutic use)
- Benzoxepins
(therapeutic use)
- Collagen
- Coronary Disease
(chemically induced, drug therapy, physiopathology)
- Cyclooxygenase Inhibitors
(pharmacology)
- Electrocardiography
(drug effects)
- Guinea Pigs
- Heart Arrest
(chemically induced, physiopathology)
- Male
- Nifedipine
(therapeutic use)
- Phenylacetates
(pharmacology)
- Propranolol
(therapeutic use)
- Sulfonamides
(pharmacology)
- Thromboxane A2
(antagonists & inhibitors)
- Thromboxane B2
(blood)
- Thromboxanes
(antagonists & inhibitors)
- Ticlopidine
(therapeutic use)
|